SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-006674
Filing Date
2021-02-04
Accepted
2021-02-04 09:00:56
Documents
5
Period of Report
2021-02-01
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea134354-8k_wizepharma.htm 8-K 35054
2 BIDDER'S STATEMENT, DATED FEBRUARY 1, 2021 ea134354ex99-1_wize.htm EX-99.1 1036992
3 GRAPHIC ex99-1_001.jpg GRAPHIC 4686
4 GRAPHIC ex99-1_002.jpg GRAPHIC 2608
5 GRAPHIC ex99-1_003.jpg GRAPHIC 151453
  Complete submission text file 0001213900-21-006674.txt   1286841
Mailing Address 24 HANAGAR ST HOD HASHARON L3 4527713
Business Address 24 HANAGAR ST HOD HASHARON L3 4527713 972 472 260 0536
Wize Pharma, Inc. (Filer) CIK: 0001218683 (see all company filings)

IRS No.: 880445167 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-52545 | Film No.: 21589005
SIC: 2834 Pharmaceutical Preparations